Search by Drug Name or NDC

    NDC 00409-3796-01 Ketorolac Tromethamine 60 mg/2mL Details

    Ketorolac Tromethamine 60 mg/2mL

    Ketorolac Tromethamine is a INTRAMUSCULAR INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is KETOROLAC TROMETHAMINE.

    Product Information

    NDC 00409-3796
    Product ID 0409-3796_be3c3d59-deb5-4116-a5a9-155df6c495c4
    Associated GPIs 66100037102071
    GCN Sequence Number 031613
    GCN Sequence Number Description ketorolac tromethamine VIAL 60 MG/2 ML INTRAMUSC
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 35236
    HICL Sequence Number 005175
    HICL Sequence Number Description KETOROLAC TROMETHAMINE
    Brand/Generic Generic
    Proprietary Name Ketorolac Tromethamine
    Proprietary Name Suffix n/a
    Non-Proprietary Name KETOROLAC TROMETHAMINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR
    Active Ingredient Strength 60
    Active Ingredient Units mg/2mL
    Substance Name KETOROLAC TROMETHAMINE
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitor [EPC], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074802
    Listing Certified Through 2024-12-31

    Package

    NDC 00409-3796-01 (00409379601)

    NDC Package Code 0409-3796-01
    Billing NDC 00409379601
    Package 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-3796-01) / 2 mL in 1 VIAL, SINGLE-DOSE (0409-3796-19)
    Marketing Start Date 2015-10-30
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.76863
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description KETOROLAC 60 MG/2 ML VIAL
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis